Conditions: Sarcoma; Epithelioid Sarcoma; Cutaneous Angiosarcoma
Interventions: Drug: Talimogene Laherparepvec (T-VEC); Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center; Amgen; Merck Sharp & Dohme LLC
Active, not recruiting
14797 items (14797 unread) in 74 feeds